Nanocontamination of the Soldiers in a Battle Space

  • A.M. GattiEmail author
  • S. Montanari
Part of the NATO Science for Peace and Security Series C: Environmental Security book series (NAPSC)


The paper deals with the unusual pathologies some soldiers contracted after exposure in battle theatres in Iraq and in the Balkans, and considers the hypotheses the Authors developed to explain the origin of those diseases, that proved to be lethal in a few cases. The scenario of particulate nanopollution generated by high-temperature combustions characteristic of some weapons is described. The electron-microscopy observations carried out in 37 soldiers' pathological tissues verified the internal dissemination of toxic metallic micro and nano-particles. The article considers the way of entrance of those nanopollutants: the lung for inhalation and the digestive system for the ingestion of polluted food. Battle theatre pollution is also discussed.


Amyotrophic Lateral Sclerosis Chronic Fatigue Syndrome Firing Ground Gulf Syndrome Deplete Uranium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Iversen A, Chalder T, Wessely S. Gulf War illness: lessons from medically unexplained symptoms. Clin Psychol Rev. 2007 Oct; 27(7):842–854. Epub 2007 Jul 17. Review.PubMedCrossRefGoogle Scholar
  2. 2.
    McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Jacobson-Kram D, Squibb KS. Health surveillance of Gulf War I veterans exposed to depleted uranium: updating the cohort. Health Phys. 2007 July; 93(1):60–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, Kasarskis EJ. Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: evidence for a time-limited outbreak. Neuroepidemiology. 2008 June 6; 31(1):28–32.PubMedCrossRefGoogle Scholar
  4. 4.
    Verret C, Jutand MA, De Vigan C, Bégassat M, Bensefa-Colas L, Brochard P, Salamon R. Reproductive health and pregnancy outcomes among French gulf war veterans. BMC Public Health. 2008 Apr 28; 8:141.PubMedCrossRefGoogle Scholar
  5. 5.
    Nelson C. Veterans' mysterious maladies: studies continue to examine the effects of depleted uranium on returning soldiers. State Legis. 2008 May; 34(5):28–29.PubMedGoogle Scholar
  6. 6.
    Hokama Y, Empey-Campora C, Hara C, Higa N, Siu N, Lau R, Kuribayashi T, Yabusaki K. Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J Clin Lab Anal. 2008 22(2):99–105.PubMedCrossRefGoogle Scholar
  7. 7.
    Golomb BA. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4295–300. Epub 2008 Mar 10.PubMedCrossRefADSGoogle Scholar
  8. 8.
    Hooper TI, Debakey SF, Nagaraj BE, Bellis KS, Smith B, Smith TC, Gackstetter GD. The long-term hospitalization experience following military service in the 1991 Gulf War among veterans remaining on active duty, 1994-2004. BMC Public Health. 2008 Feb 13; 8:60.PubMedCrossRefGoogle Scholar
  9. 9.
    Cazoulat A, Lecompte Y, Bohand S, Castagnet X, Laroche P. Urinary uranium analysis results on Gulf war or Balkans conflict veterans, Pathol Biol (Paris). 2008 Mar; 56(2):77–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Pols H, Oak S. War & military mental health: the US psychiatric response in the 20th century. Am J Public Health. 2007 Dec; 97(12):2132–2142.PubMedCrossRefGoogle Scholar
  11. 11.
    Levine PH, Richardson PK, Zolfaghari L, Cleary SD, Geist CE, Potolicchio S, Young HA, Simmens SJ, Schessel D, Williams K, Mahan CM, Kang HK. A study of Gulf War veterans with a possible deployment-related syndrome. Arch Environ Occup Health. 2006 Nov–Dec; 61(6):271–278.PubMedCrossRefGoogle Scholar
  12. 12.
    Barach P, Brautbar N, Richter ED, Friedman L. Latency: an important consideration in Gulf War syndrome. Neurotoxicology. 2007 Sep; 28(5):1043–4; author reply 1044– 1045.PubMedCrossRefGoogle Scholar
  13. 13.
    Ismail K, Kent K, Sherwood R, Hull L, Seed P, David AS, Wessely S. Chronic fatigue syndrome and related disorders in UK veterans of the Gulf War 1990-1991: results from a two-phase cohort study. Psychol Med. 2008 July; 38(7):953–961.PubMedCrossRefGoogle Scholar
  14. 14.
    Gatti, A, Montanari S. Approccio bioingegneristico alla sindrome dei Balcani, Fisica in Medicina, 2004, 2:107–114.Google Scholar
  15. 15.
    DU in Bosnia ed Erzegovina in Post Conflict Environmental Assessment, United Nations Environment Programme, Switzerland 2003 ( Scholar
  16. 16.
    Technical Report of the Air Force Armament Laboratory — Armament Development and Test Center, Eglin Air Force Base, FL, USA, From October 1977 to October 1978, Project no. 06CD0101Google Scholar
  17. 17.
    Report of Parliamentary Committee of Inquiry into cases of death and serious illness among Italian Military personnel engaged in International peace missions and into the storage conditions of Depleted uranium and its possible use in military exercise on national soil”, 2004, XIV LEGISLATURA, Doc. XXII-bis, no. 4.Google Scholar
  18. 18.
    Report of the “Parliamentary Committee of Inquiry on the cases of death and severe illnesses affecting Italian personnel assigned to military missions abroad, firing ranges and the sites where munitions are stocked, as well as civilian populations in war zones and in areas adjacent to military bases on the national territory, with special attention to the effects of depleted uranium shells and of the dispersion in the environment of nanoparticles of heavy minerals produced by the explosion of warfare material”, 11 October 2006, Doc. XXII-bis, no. 2. Available at: repository/commissioni/uranio15/final_report.pdfGoogle Scholar
  19. 19.
    Nemmar A., Hoet P.H.M., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M.F., Vanbilloen H., Mortelmans L., Nemery B. Passage of inhaled particles in to the blood circulation in humans, Circulation. 2002; 105(4):411–441.PubMedCrossRefGoogle Scholar
  20. 20.
    Gatti A, Montanari S. Nanopathology: The health impact of nanoparticles — Ed. By Pan Stanford - Singapore 2008 ( /nanosci/v001.html).Google Scholar
  21. 21.
    Durakovic A, Horan, D, The quantitative analysis of depleted Uranium isotopes in British, Canadian and US Gulf war Veteran, Mil Med. 2002; 167(8):620.PubMedGoogle Scholar
  22. 22.
    Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C., Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004 June; 16(6–7):437–445.PubMedCrossRefGoogle Scholar
  23. 23.
    Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006 Aug; 114(8):1172–1178. Erratum in: Environ Health Perspect. 2006 Aug; 114(8):1178.PubMedCrossRefGoogle Scholar
  24. 24.
    Gatti A, Montanari S, Nanopollution: the invisible fog of future wars, The futurist. 2008 May–June 32–34.Google Scholar

Copyright information

© Springer Science + Business Media B.V. 2009

Authors and Affiliations

  1. 1.Laboratory of Biomaterials University of Modena and ReggioEmiliaModenaItaly
  2. 2.Nanodiagnostics srl ModenaItaly

Personalised recommendations